← Search

Text · study · 2026

Kinome CRISPR screen for Rhabdomyosarcoma cells in combination with pralatrexate

Listed in NCBI GEO

We found that pralatrexate causes temporary tumor regression in RH4 cell xenograft model.

Description

In order to identify possible therapeutic targets that could be targeted in combination with pralatrexate, we performed a whole Kinome CRISPR loss of function screen in cells dosed with pralatrexate.

Links

Topics

Stated by source
Homo sapiens · Other
From keywords
Life Sciences
Inferred from text
Cancer 65%
Provenance · 1 source records, 8 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE31486214 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[disease].local:disease:cancerenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (65%)
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:othersource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[organism].NCBITaxon:9606source · NCBI GEOconnector:ncbi_geo@1.0.0/taxon
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title